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a  b  s  t  r  a  c  t
Introduction:  Kikuchi-Fujimoto  disease  or histiocytic  necrotizing  lymphadenitis  is a benign  disease  of
unknown  origin  predominantly  affecting  young  women  and  presenting  in  the form  of  cervical  lym-
phadenopathy  and/or  prolonged  fever.
Material  and methods:  The  authors  report  4 cases  of  Kikuchi-Fujimoto  disease  diagnosed  in the  Internal
Medicine  Department  of  Ibn  Sina  university  hospital  in  Rabat  between  2009  and  2010.
Results:  These  4 women  with  a mean  age  of 27  ± 8.6  years  [16–37]  were  admitted  with  febrile  syndrome
and  cervical  lymphadenopathy.  The  diagnosis  was based  on  histological  examination  of  a lymph  node
biopsy.  The  disease  was  associated  with  systemic  lupus  erythematosus  in one  case  and  actinomycosis
in  another  case.  A  favourable  course  was  observed  in  response  to corticosteroid  therapy  in two  patients,
antibiotic  therapy  in  one  patient  and  antipyretic  treatment  alone  in  the fourth  patient.
Conclusion:  In the  light  of these  four  cases,  the  authors  discuss  the  diagnostic  difﬁculties,  the  modalities
of  treatment  of  Kikuchi-Fujimoto  disease  and  its clinical  course.. Introduction
Kikuchi-Fujimoto disease or histiocytic necrotizing lym-
hadenitis is a rare, benign disease presenting in the form of
ervical lymphadenopathy, frequently associated with a series
f systemic manifestations. The pathophysiology of this disease
emains unclear and may  be associated with autoimmune diseases,
specially systemic lupus erythematosus and certain infectious
gents. We  report the cases of four women with Kikuchi-Fujimoto
isease.
. Material and methods
This retrospective study was based on 4 cases of Kikuchi-
ujimoto disease observed in the Internal Medicine Department
f Rabat University Hospital between 2009 and 2010. The diagno-
is was established on the basis of a complete clinical, laboratory
nd radiological assessment, as well as histological examination of
 lymph node biopsy.
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3. Results
The mean age of the patients was 27 years (range: 16 to
37 years). Epidemiological, clinical, laboratory and radiological
characteristics are summarized in Tables 1–4, respectively.
Cervical lymph nodes, conﬁrmed by ultrasound, were ﬁrm, mea-
suring about 2 cm in diameter, mobile, painless and not associated
with any local inﬂammatory signs.
Histological examination of a cervical lymph node biopsy in all
four patients revealed lymphoid tissue with perfectly conserved
architecture. The presence of clear zones composed of histiocytes
surrounding apoptotic cells comprising nuclei with dense chro-
matin or fragmented nuclei was  observed in paracortical zones of
the lymph node. No pathogens, tuberculoid granuloma, or caseous
necrosis were observed. Immunolabelling with anti-CD20 and anti-
CD3 antibodies demonstrated a homogeneous distribution of B and
T lymphocyte populations (Fig. 1) and a large population of CD68+
histiocytes (Fig. 2), an appearance suggestive of Kikuchi-Fujimoto
histiocytic necrotizing lymphadenitis.
Laryngoscopy, performed in one patient due to the presence of
an enlarged parotid gland, demonstrated a non-bleeding granu-
lating appearance. Histological examination of a nasopharyngeal
biopsy demonstrated chronic inﬂammatory changes with the pres-
ence of Actinomyces.
In one patient, Kikuchi-Fujimoto disease was associated with
systemic lupus erythematosus (SLE), a diagnosis based on the
presence of suggestive clinical features as well as a positive
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Table  1
Epidemiological characteristics.
Case 1 Case 2 Case 3 Case 4
Age 37 years 16 years 28 years 26 years
Gender  Female Female Female Female
Ethnic  origin Moroccan Moroccan Moroccan Moroccan
History  Nil Tonsillectomy 4 years ago Nil Penicillin allergy
Table 2
Clinical characteristics.
Case 1 Case 2 Case 3 Case 4
History of the present illness Fever Fever Inﬂammatory polyarthralgia Bilateral parotid and neck swelling
General malaise General malaise Face rash Fever, general malaise
For  3 months For 3 months Fever, general malaise For 4 months
2  months postpartum
Physical examination T◦ = 38.5 ◦C T◦ = 40 ◦C T◦ = 39 ◦C T◦ = 38 ◦C
Bilateral cervical and axillary
lymph nodes
Bilateral cervical and axillary
lymph nodes
Malar rash Parotid hypertrophy
Bilateral cervical lymph nodes Bilateral cervical lymph nodes
Table 3
Laboratory characteristics.
Laboratory parameter Case 1 Case 2 Case 3 Case 4
CBC: Hb (g/dL) 11 11.6 10.5 12.5
WBC  (/mm3) 4000 2800 2900 5300
Lymphocytes (/mm3) 1000 896 900 2100
Platelets (/mm3) 250,000 147,000 155,000 260,000
ESR  (mm)  40 49 70 12
CRP  (mg/L) 6 8 60 4
PE  Normal Normal Polyclonal hypergammaglobulinaemia Normal
IDR  + AFB Negative Negative Negative Negative
Serologya Negative Negative Negative Negative
24-hour proteinuria Negative Negative Negative Negative
ANA  Negative Negative 1/1280 (homogeneous ﬂuorescence) Negative
Anti-DNA 1/40
SA  + bone marrow biopsy Normal Normal Normal













Rrythrocyte sedimentation rate ; ANA: antinuclear antibody; CRP: C reactive protei
a Rubella, hepatitis B-C, HIV, Cytomegalovirus, Toxoplasmosis.
mmunological work-up. In another patient, Kikuchi-Fujimoto dis-
ase was associated with actinomycosis.
Treatments and clinical course are reported in Table 5. Patient
ollow-up was based on physical examination and ultrasound.
. Discussion
Kikuchi-Fujimoto disease was described for the ﬁrst time in
972 in Japan simultaneously by two pathologists, Kikuchi and
ujimoto [1,2]. It has been subsequently reported sporadically in
arious countries, predominantly in Japan (80% of cases) [3,4]. It can
ccur at all ages (range: 5 to 75 years), but predominantly affects
oung adults with a mean age of 25 to 30 years with a female pre-
ominance in the majority of series [3–8]. The mean age of the
able 4
adiological characteristics.
Case 1 Case 2 
Chest X-ray Normal Normal 
Abdominal ultrasound Normal Normal 




Chest, abdomen, pelvis CT scan Normal Normal 
Laryngoscopy  sternal aspiration.
patients in this series was  27 ± 8.6 years, in accordance with the
epidemiological data concerning this disease.
Clinical features are dominated by the presence of cervical lym-
phadenopathy in more than 80% of cases, usually located in the
trapezius or jugular and carotid lymph node chains, as observed in
our patients [8]. Lymph nodes are ﬁrm, sometimes very large mea-
suring 2 to 6 cm in diameter, mobile, but rarely painful and never
ulcerating [3–5,8]. Systemic signs, predominantly fever, were also
present in our patients and have been reported in 30 to 50% of
cases [8]. They often constitute the predominant clinical features,
wrongly suggesting an infectious cause or a haematological malig-
nancy. A pseudo-urticarial rash, hepatosplenomegaly, arthralgia,
weight loss or deep lymph nodes (mediastinal, retroperitoneal)
may  also be present [8].
Case 3 Case 4
Normal Normal
Normal Normal
mph Bilateral cervical lymph
nodes
Homogeneous
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Table  5
Treatment – outcome.
Case 1 Case 2 Case 3 Case 4




Treatment Antipyretics Oral corticosteroids 1 mg/kg/day Oral corticosteroids 1 mg/kg/day Tetracyclines 200 mg/day
Outcome Favourable after 1 month Favourable after 1 month 
Follow-up 8 months (asymptomatic) 6 months (asymptomatic) 
Fig. 1. Histological section of a cervical lymph node biopsy showing nonsuppura-












heaction and a homogeneous distribution of B and T lymphocytes presenting anti-
D20 and anti-CD3 antibody staining.
Laboratory abnormalities are inconstant and nonspeciﬁc:
nﬂammatory syndrome and granulocytopenia are classically
eported, as observed in three of our patients [8]. Leukocytosis is
xceptional [3] and atypical lymphocytes were described in 25 to
3% of patients in two series [5].
Various clinical and histological diagnoses can be considered in
he context of a combination of lymphadenopathy and fever, as
ymphoma or SLE can present similar clinical features. Infectious
ymphadenitis can also be considered, especially tuberculosis, cat
cratch fever, infectious mononucleosis, toxoplasmosis, yersiniosis
ig. 2. Histological section of a cervical lymph node biopsy showing a large CD68+
istiocyte population.Synthetic antimalarial
Favourable after 1 month Favourable after 1 month
8 months (asymptomatic) 4 months (asymptomatic)
and herpes virus, cytomegalovirus and human immunodeﬁciency
virus infection.
Diagnostic conﬁrmation of this disease is based on histolog-
ical examination of a lymph node with immunolabelling [9,10].
The main histological features were summarized by Diebold [10].
Lymph nodes present features of follicular hyperplasia, but their
architecture is preserved. Histological lesions comprise acidophilic
necrosis of the paracortical zone with the presence of numerous
histiocytes, including plasma cells and large lymphoid cells, but no
polymorphonuclear neutrophils and no caseous necrosis. Immuno-
histochemical analysis shows that the cells present in pathological
zones of the node are mainly CD3+ cells and histiocytes expressing
lysozyme, representing about 60% of all mononuclear cells. The cell
population is predominantly composed of CD68+ histiocytes, while
the lymphocyte population represents 20 to 50% of the total cell
population, mainly CD8+ cytotoxic T lymphocytes. The CD4/CD8
ratio varies from 1/4 to 4/1. These heterogeneous results could
reﬂect different immunological stages of Kikuchi-Fujimoto dis-
ease. The CD8+ lymphocyte count and the CD8/CD4 ratio gradually
increase after onset of the disease, and the CD8+ count then gradu-
ally decreases, while the CD4+ count increases. CD8+ lymphocytes
are then transformed into immunoblasts. Very few B lymphocytes
are observed. According to Kishimoto, CD123 positivity is required
to conﬁrm the diagnosis of Kikuchi-Fujimoto disease [11]. Three
histopathological subtypes have been deﬁned: typical necrotic for;
pseudoneoplastic proliferative form and xanthomatous form [5].
These histological features were present in our patients, with high
CD68 expression reﬂecting histiocyte proliferation.
The pathogenesis of Kikuchi-Fujimoto disease remains
unknown and, although several hypotheses have been pro-
posed, no aetiology has been formally demonstrated. Some
authors consider that Kikuchi-Fujimoto disease could be due to a
nonspeciﬁc immune reaction to various infectious antigens such
as Toxoplasma gondii,  Yersinia enterocolitica, herpes viruses HHV6
and HHV8, EBV, parvovirus B19 and CMV  [12–14].
Concomitant actinomycosis was  demonstrated in one of our
patients, with no speciﬁc features on histological examination of
the lymph node. To the best of our knowledge, the possible asso-
ciation between Kikuchi-Fujimoto disease and actinomycosis has
not been previously reported in the literature, but the favourable
course of Kikuchi-Fujimoto disease in response to antibiotics could
support the hypothesis of a direct link between the two diseases
that needs to be more clearly elucidated by more detailed studies.
An immune disorder has been proposed, as several patients
with Kikuchi-Fujimoto disease also presented a systemic disease,
especially mixed connective tissue diseases [15–18]. The most
commonly reported association is that with SLE, described in
about 30 cases [8,19–22]. A close correlation has been reported
between Kikuchi-Fujimoto disease and SLE and some authors
consider Kikuchi-Fujimoto disease to be a limited lymph node
form of lupus that may  subsequently progress to systemic lupus
erythematosus [8,23]. These two diseases share a number of
characteristics in common: female predominance, young age,
lymphadenopathy, lymphopenia, arthralgia and the presence
of tubuloreticular structures on electron microscopy of lymph
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imultaneously or several weeks to several years after the initial
iagnosis of SLE. Lymphadenopathy is present in 19 to 67% of cases
f SLE and constitutes the ﬁrst sign of the disease in 2% of cases
13]. Histology usually revealed nonspeciﬁc lymphadenitis, but
eatures of necrotizing lymphadenitis, similar to those observed in
ikuchi-Fujimoto disease, may  also be observed, but with a pre-
ominance of B lymphocytes, in contrast with the predominance
f T lymphocytes observed in Kikuchi-Fujimoto disease [3,8,10,23].
In the present series, systemic lupus erythematosus was  diag-
osed in one patient, who presented butterﬂy rash of the face,
nﬂammatory polyarthralgia, lymphopenia, and positive antinu-
lear and anti-native DNA antibodies.
Kikuchi-Fujimoto disease has a favourable course in the major-
ty of cases, resolving spontaneously over an average of 3 months
1 to 24 months) with regression of lymphadenopathy and reso-
ution of systemic signs [4,24]. Deaths reported in the literature
oncerned forms associated with systemic diseases [3,23]. Corticos-
eroid therapy is considered to be the reference treatment in these
ases. It is administered at doses ranging from 0.25 to 1 mg/kg per
ay, sometimes starting with a bolus of methylprednisolone (500
o 1000 mg/day for 3 days) depending on the severity of the clinical
eatures. Relapses are observed in 2 to 3% of cases [3,5,25], with a
imilar course.
The ﬁrst patient in this series was treated by antipyretics only, as
he remained in good general health with only moderate fever. In
he second case, corticosteroid therapy was indicated in view of the
evere febrile syndrome and general malaise. The presence of SLE in
he third patient constituted an indication for corticosteroids and
ynthetic antimalarials and antibiotic therapy alone was  effective
n the fourth patient with concomitant actinomycosis. A favourable
ourse was observed in all four cases, with complete resolution of
linical and laboratory signs after 1 month.
. Conclusion
Kikuchi-Fujimoto disease is a relatively rare, but probably
nderestimated cause of lymphadenopathy in young adults. It
ssentially raises the problem of the differential diagnosis with
arious diseases that may  simulate lymphoma, lymph node tuber-
ulosis or lupus adenitis. Conﬁrmation of the diagnosis is based
n histological examination of a lymph node biopsy, particularly
mmunohistochemistry. Kikuchi-Fujimoto disease usually has a
pontaneously favourable clinical course. These patients require
rolonged follow-up due to the risk of subsequent onset of an
utoimmune disease, especially systemic lupus erythematosus.isclosure of interest
The authors declare that they have no conﬂicts of interest con-
erning this article.
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